サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468336

経カテーテル大動脈弁移植市場：手技、エンドユーザー、地域別、2024～2032年

Transcatheter Aortic Valve Implantation Market by Procedure, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
経カテーテル大動脈弁移植市場：手技、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル大動脈弁移植の世界市場規模は、2023年に63億米ドルに達しました。今後、IMARC Groupは、2024～2032年の間に10.65%の成長率（CAGR）を示し、2032年までに161億米ドルに達すると予測しています。冠動脈疾患の有病率の増加、低侵襲治療の採用率の上昇、高齢者人口の拡大などが市場を牽引する主要要因です。

経カテーテル大動脈弁移植（TAVI）とは、大動脈弁が狭くなって心臓から全身への血流が減少する心臓疾患である大動脈弁狭窄症の治療に用いられる低侵襲の外科手術を指します。手術では、患者の鼠径部または胸部を小さく切開します。カテーテルが挿入され、大腿動脈または大動脈を通って狭くなった大動脈弁に導かれます。動物組織や合成材料などの生物学的材料で作られた人工弁がカテーテルを通して展開され、狭くなった弁の内側に配置されます。TAVIは局所麻酔で行うことができます。従来の手術に比べ、回復時間が短く、合併症のリスクも低いため、病気や虚弱で開心術を受けられない患者さんにも行うことができます。

経カテーテル大動脈弁移植市場動向：

心不全、高血圧、冠動脈疾患、心血管疾患（CVDs）、特に大動脈弁狭窄症に罹患する患者数の増加が、経カテーテル大動脈弁移植市場の成長を主に牽引しています。これに加えて、在院日数の短縮、回復時間の短縮、転帰の改善、医療費全体の削減などの利点から、従来の開心術よりも低侵襲手術（MIS）を好む消費者のシフトが、市場に明るい展望を生み出しています。さらに、大動脈弁疾患に対する消費者の意識の高まりと、早期診断とタイムリーな治療につながる利用可能な治療オプションが、市場の成長に寄与しています。これに加えて、研究開発（R&D）イニシアティブへの広範な資金提供や、生体弁、自己拡大型弁、その他の革新的デバイスの開発など、TAVI手技における継続的な技術進歩が市場成長を強化しています。さらに、医療産業の成長強化、臨床試験の増加、継続的な製品革新、高齢者人口の拡大、有利な償還政策などが、市場に有益な成長機会をもたらしています。

本レポートで扱う主要質問

  • 経カテーテル大動脈弁移植の世界市場規模は？
  • 2024～2032年にかけての経カテーテル大動脈弁移植世界市場の予想成長率は？
  • 経カテーテル大動脈弁移植の世界市場を牽引する主要因は？
  • COVID-19が経カテーテル大動脈弁移植の世界市場に与えた影響は？
  • 経カテーテル大動脈弁移植の世界市場における手技別の区分は？
  • 世界の経カテーテル大動脈弁移植市場のエンドユーザー別の区分は？
  • 経カテーテル大動脈弁移植の世界市場における主要地域は？
  • 経カテーテル大動脈弁移植の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 経カテーテル大動脈弁移植の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：手技別

  • 経大腿手技
  • 経カテーテル手術
  • 経大動脈的移植

第7章 市場内訳：エンドユーザー別

  • 病院
  • 診断ラボ
  • 外来手術センター
  • クリニック
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • JC Medical Inc.（Genesis Medtech International Private Limited）
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • NVT AG（Biosensors International Group）
    • Venus Medtech（Hangzhou）Inc.
図表

List of Figures

  • Figure 1: Global: Transcatheter Aortic Valve Implantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Aortic Valve Implantation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Procedure (in %), 2023
  • Figure 5: Global: Transcatheter Aortic Valve Implantation Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transcatheter Aortic Valve Implantation (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transcatheter Aortic Valve Implantation (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: North America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: North America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: United States: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: United States: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Canada: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Canada: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Asia-Pacific: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Asia-Pacific: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: China: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: China: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Japan: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Japan: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: India: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: India: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: South Korea: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: South Korea: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Australia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Australia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Indonesia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Indonesia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Europe: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Europe: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Germany: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Germany: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: France: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: France: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United Kingdom: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United Kingdom: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Italy: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Italy: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Spain: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Spain: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Russia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Russia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Brazil: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Brazil: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Mexico: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Mexico: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Breakup by Country (in %), 2023
  • Figure 71: Middle East and Africa: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Global: Transcatheter Aortic Valve Implantation Industry: Drivers, Restraints, and Opportunities
  • Figure 73: Global: Transcatheter Aortic Valve Implantation Industry: Value Chain Analysis
  • Figure 74: Global: Transcatheter Aortic Valve Implantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Aortic Valve Implantation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Transcatheter Aortic Valve Implantation Market: Competitive Structure
  • Table 6: Global: Transcatheter Aortic Valve Implantation Market: Key Players
目次
Product Code: SR112024A7501

The global transcatheter aortic valve implantation (TAVI) market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.65% during 2024-2032. The increasing prevalence of coronary artery disease, the rising adoption of minimally invasive therapies, and the expanding geriatric population represent some of the key factors driving the market.

Transcatheter Aortic Valve Implantation (TAVI) refers to a minimally invasive surgical procedure used to treat aortic stenosis, a heart condition in which the aortic valve narrows, resulting in reduced blood flow from the heart to the rest of the body. During the procedure, a small incision is made in the patient's groin or chest. A catheter is inserted and guided through the femoral artery or the aorta to the narrowed aortic valve. An artificial valve made of biological material, such as animal tissue or synthetic materials, is deployed through the catheter and positioned inside the narrowed valve, which expands to replace the old valve, allowing blood to flow freely from the heart. TAVI can be performed under local anesthesia. Compared to traditional surgery, it has a shorter recovery time and a lower risk of complications and can be performed on patients who are too ill or frail to undergo open-heart surgery.

Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The growing number of patients suffering from heart failure, hypertension, coronary artery disease, and cardiovascular diseases (CVDs), particularly aortic stenosis, is primarily driving the transcatheter aortic valve implantation (TAVI) market growth. Besides this, the shifting consumer preference for minimally invasive surgery (MIS) over conventional open-heart surgery due to its advantages, such as reduced hospital stay, shorter recovery time, improved outcomes, and lower overall healthcare spending, is creating a positive outlook for the market. Moreover, the escalating consumer awareness about aortic valve disease and available treatment options leading to early diagnosis and timely treatment is contributing to the market growth. In addition to this, the extensive funding in research and development (R&D) initiatives and ongoing technological advancements in the TAVI procedure, such as the development of bioprosthetic valves, self-expanding valves, and other innovative devices, are strengthening the market growth. Furthermore, the bolstering growth of the healthcare industry, the increasing number of clinical trials, continuous product innovations, the expanding geriatric population, and favorable reimbursement policies are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global transcatheter aortic valve implantation (TAVI) market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on procedure and end user.

Procedure Insights:

Transfemoral Procedure

Transapical Implantation

Transaortic Implantation

The report has provided a detailed breakup and analysis of the transcatheter aortic valve implantation (TAVI) market based on the procedure. This includes the transfemoral procedure, transapical implantation, and transaortic implantation. According to the report, transfemoral procedure represented the largest segment.

End User Insights:

Hospitals

Diagnostic Labs

Ambulatory Surgical Centers

Clinics

Others

A detailed breakup and analysis of the transcatheter aortic valve implantation (TAVI) market based on the end user has also been provided in the report. This includes hospitals, diagnostic labs, ambulatory surgical centers, clinics, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for transcatheter aortic valve implantation (TAVI). Some of the factors driving the North America transcatheter aortic valve implantation (TAVI) market included the expanding prevalence of cardiovascular diseases, the rising adoption of minimally invasive therapies, and ongoing technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter aortic valve implantation (TAVI) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 2. What is the expected growth rate of the global Transcatheter Aortic Valve Implantation (TAVI) market during 2024-2032?
  • 3. What are the key factors driving the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 4. What has been the impact of COVID-19 on the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 5. What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the procedure?
  • 6. What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the end user?
  • 7. What are the key regions in the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 8. Who are the key players/companies in the global Transcatheter Aortic Valve Implantation (TAVI) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Aortic Valve Implantation (TAVI) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Transfemoral Procedure
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transapical Implantation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Transaortic Implantation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Labs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Boston Scientific Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Edwards Lifesciences Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JC Medical Inc. (Genesis Medtech International Private Limited)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Medtronic plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Meril Life Sciences Pvt. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NVT AG (Biosensors International Group)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Venus Medtech (Hangzhou) Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.